期刊文献+

特发性血小板减少性紫癜的定向免疫干预 被引量:2

原文传递
导出
出处 《中华内科杂志》 CAS CSCD 北大核心 2006年第4期344-346,共3页 Chinese Journal of Internal Medicine
基金 国家自然科学基金资助项目(30300312 30470742)
  • 相关文献

参考文献21

  • 1Olsson M,Bruhns P,Frazier WA,et al.Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia.Blood,2005,105:3577-3582.
  • 2Jin F,Balthasar JP.Mechanisms of Intravenous immunoglobulin action in immune thrombocytopenic purpura.Hum Immunol,2005,66:403-410.
  • 3Cooper N,Heddle NM,Haas M,et al.Intravenous (Ⅳ) anti-D and Ⅳ immunoglobulin achieve acute platelet increase by different mechanisms:modulation of cytokine and platelet responses to Ⅳ anti-D by FcgammaRⅡa and FcgammaRⅢa polymorphisms.Br J Haematol,2004,124:511-518.
  • 4Song S,Crow AR,Freedman J,et al.Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP:alternative to IVIG.Blood,2003,101:3708-3713.
  • 5Stasi R,Pagano A,Stipa E,et al.Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.Blood,2001,98:952-957.
  • 6Braendstrup P,Bjerrum OW,Nielsen OJ,et al.Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.Am J Hematol,2005,78:275-280.
  • 7McMillan R,Wang L,Tomer A,et al.Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.Blood,2004,103:1364-1369.
  • 8Bussel JB,George JN,Kuter DJ,et al.An open-label,dose-finding study evaluating the safety and platelet response of a novel thrombopoietic protein (AMG 531) in thrombocytopenic adult patients with immune thrombocytopenic purpura.Blood,2003,102:86a.
  • 9赵永强,王庆余,翟明,徐健,陈协群,刘文励,张梅,宋善俊,王健民,孟凡义,单渊东.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的多中心临床试验[J].中华内科杂志,2004,43(8):608-610. 被引量:104
  • 10Kuwana M,Kaburaki J,Ikeda Y.Autoreactive T cells to platelet GPⅡ b/Ⅲa in immune thrombocytopenic purpura:role in production of anti-platelet autoantibody.J Clin Invest,1998,102:1393-1402.

二级参考文献12

  • 1Kosugi S, Kurata Y, Tomiyama Y, et al. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Br J Haematol,1996, 93:704-706.
  • 2Usuki K, Tahara T, Iki S, et al. Serum thrombopoietin level in various hematological diseases. Stem Cells, 1996, 14:558-565.
  • 3yon dem Borne A, Folman C, van den Oudenrijn S, et al. The potential role of thrombopoietin in idiopathic thrombocytopenic purpura. Blood Rev, 2002, 16:57-59.
  • 4British Committee for Standerds in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol, 2003,120,574-596.
  • 5Stasi R, Brunetti M, Pagano A, et al. Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura. Blood Cells Mol Dis, 2000, 26:582-586.
  • 6Wali YA, AL Lamki, Shah W, et al. Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol, 2002, 19:329-335.
  • 7Cheng Y, Wong RS, Soo YO, et al. Initial treatment of immune thrombocytopenic purpura with high-Dose dexamethasone. N Engl J Med, 2003,349: 831-836.
  • 8张源慧.特发性血小板减少性紫癜[A].见:张之南 沈悌 主编.血液病诊断及疗效标准 第2版[C].北京:科学出版社,1998.279-285.
  • 9廖小梅,唐雪梅,邓承祺,牛挺,孟文彤.血小板生成素和白细胞介素-11对慢性特发性血小板减少性紫癜巨核细胞的影响[J].华西医科大学学报,2001,32(4):572-575. 被引量:16
  • 10李蔚,侯明,张茂宏,朱媛媛,马道新.自身免疫性血小板减少性紫癜的特异性免疫学诊断的研究[J].中华血液学杂志,2001,22(7):374-376. 被引量:39

共引文献146

同被引文献20

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部